Xunjia Li

Dr. Xunjia Li


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2024 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
DZDeyu Zuo
Deyu Zuo
MLMinghao Luo
Minghao Luo
CLChengxuan Liu
Chengxuan Liu
AYAimin Yang
Aimin Yang
YSYoufeng Shen
Youfeng Shen
XLXunjia Li
Xunjia Li

4 February 2023 in Journal of Chemistry
Verified
Journal Article
Open access
PDF file
WXWeijian Xiong
Weijian Xiong
YLYing Li
Ying Li
LZLing Zhang
Ling Zhang
YXYanying Xiong
Yanying Xiong
JZJin Zhong
Jin Zhong
YCYunjie Chen
Yunjie Chen
Lupus nephritis (LN) is one of the most common clinical manifestations of systemic lupus erythematosus (SLE), causing death and disability. The current research study explored whether there was any improvement effect on LN after emodin administration. Network pharmacology was used to screen the target genes of emodin for the treatment of LN. LPS and IL-4 were employed for RAW264.7 macrophage M1/M2 polarization induction, and 0.1 HgCl2 was used for the LN rat models establishment. Flow cytometry was performed to detect the effect of 20, 40, and 80µM emodin on RAW264.7 macrophage polarization. HE and PAS staining were subsequently conducted to detect 70mg/kg emodin action on renal injury in LN rats. The effect of emodin on the content of urinary proteins and dsDNA antibodies was also determined. The results indicated that peroxisome proliferators-activated receptors gamma (PPARG) may be a target gene of emodin in LN, and emodin had no significant toxicity to macrophages at different concentrations. Compared with the control, emodin significantly inhibited LPS-induced polarization in M1 macrophages and improved that of IL-4-induced M2 macrophages. Besides, emodin alleviated kidney injury and markedly reduced the levels of urinary protein and dsDNA antibodies in rats. Moreover, after targeting interference with the PPARG expression, the improvement effect of emodin on LN is significantly reduced, indicating that emodin may relieve the symptoms of LN by activating the PPARG expression. Our study revealed that PPARG may be applied as a new therapy for LN.